BioMarin to Participate in Three Upcoming Investor Conferences BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will present at three upcoming investor conferences....
Wednesday, November 6, 2024 1 min read
Key Takeaway: BioMarin Pharmaceutical Inc. has announced its participation in three upcoming investor conferences, where management will present key information. The events will feature live audio webcasts, with archived versions accessible for a limited time post-conference. BioMarin, a biotechnology company based in San Rafael, California, has been recognized for its innovative approach to developing therapies for rare genetic conditions.
Market Sentiment Analysis
POSITIVE FACTORS
BioMarin will showcase its commitment to transparency and investor engagement.
The company has a proven track record of innovation and successful therapies.
Upcoming presentations could enhance investor interest and market visibility.
Full Press Release Details
SAN RAFAEL, Calif. , Nov. 6, 2024 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN ) today announced that management will present at three upcoming investor conferences.
An audio webcast of the presentation will be available live. You can access the webcast at: https://investors.biomarin.com/ . An archived version of the remarks will also be available through the Company's website for a limited time following the conference.
About BioMarin BioMarin is a global biotechnology company dedicated to translating the promise of genetic discovery into medicines that make a profound impact on the life of each patient. The San Rafael, California -based company, founded in 1997, has a proven track record of innovation with eight commercial therapies and a strong clinical and preclinical pipeline. Using a distinctive approach to drug discovery and development, BioMarin pursues treatments that offer new possibilities for patients and families around the world navigating rare or difficult to treat genetic conditions. To learn more, please visit www.biomarin.com .
Contacts:
Investors
Media
Traci McCarty
Marni Kottle
BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
(415) 455-7558
(650) 374-2803
SOURCE BioMarin Pharmaceutical Inc.
21 %
Frequently Asked Questions
What will BioMarin present at upcoming conferences?
BioMarin will present at three upcoming investor conferences.
How can I access the BioMarin conference webcast?
The live webcast can be accessed at https://investors.biomarin.com/.
When will the archived presentation be available?
An archived version of the presentation will be available for a limited time.
What does BioMarin focus on?
BioMarin focuses on developing medicines for rare genetic conditions.
When was BioMarin founded?
BioMarin was founded in 1997 and is based in San Rafael, California.